NCT02665273View on ClinicalTrials.gov

Greater Occipital Nerve Block With Bupivacaine for Acute Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Migraine
Interventions
PROCEDURE

Greater occipital nerve block

Bilateral greater occipital nerve block

DRUG

Bupivacaine

0.5 cc of 0.5% bupivacaine injected intradermally

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT02665273 - Greater Occipital Nerve Block With Bupivacaine for Acute Migraine | Biotech Hunter | Biotech Hunter